Skip to main content
Skip to main content
Visit Teva Global website
Search
Investor Relations
News
Events and Presentations
Financials
Quarterly Results
Interactive Financials
SEC Filings
Debt Securities
Debt Factsheet
Sustainability-Linked Bonds
Shareholder Information
Shareholder Resources
Stock Quote & Chart
Dividends and Stock Splits
Shareholder Meetings
Environmental, Social and Governance
Corporate Officers
Board of Directors
Governance and Policy Documents
ESG Progress Report
Additional Resources
Analyst Coverage
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Epidemiology
Clinical Trial Appendix
Conversion of Teva ADSs into Ordinary Shares
Menu
Search
Close
Visit Teva Global website
News
Events and Presentations
Financials
Quarterly Results
Interactive Financials
SEC Filings
Debt Securities
Debt Factsheet
Sustainability-Linked Bonds
Shareholder Information
Shareholder Resources
Stock Quote & Chart
Dividends and Stock Splits
Shareholder Meetings
Environmental, Social and Governance
Corporate Officers
Board of Directors
Governance and Policy Documents
ESG Progress Report
Additional Resources
Analyst Coverage
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Epidemiology
Clinical Trial Appendix
Conversion of Teva ADSs into Ordinary Shares
Home
Investors
>
Events and Presentations
>
Events & Presentations
>
Event Details
Event Details
Q3 2024 Teva Pharmaceutical Industries Ltd. Earnings Conference Call
November 6, 2024 8:00 AM ET
Webcast
(opens in new window)
Presentation
(opens in new window)
Transcript
(opens in new window)